Skip to content

Bence Jones Proteinuria C0004968

Published: July 22, 2026Updated: August 20, 2026

The presence of abnormal protein fragments in urine, often linked to plasma cell disorders. It primarily affects adults and requires investigation for underlying conditions. Treatment depends on the underlying cause.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Bone pain

(hematologic)

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Fatigue

(hematologic)

Recurrent infections

(hematologic)

Weight loss

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Chemotherapy/Immunomodulatory therapy

Treatment focuses on the underlying plasma cell dyscrasia causing Bence Jones proteinuria. Common approaches include proteasome inhibitors, immunomodulatory drugs, and corticosteroids to reduce abnormal protein production by malignant plasma cells.

medication
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Serial serum free light chain analysis

Regular monitoring of serum free light chain levels to assess disease response and progression. This provides more sensitive detection of treatment response compared to urine protein measurements alone.

monitoring

Additional treatment options

Bisphosphonate therapy

Administered to prevent skeletal-related events and reduce bone pain associated with plasma cell disorders. Helps maintain bone density and reduces fracture risk in patients with lytic lesions.

medication

Renal-protective nutritional support

Dietary modifications to support kidney function including adequate hydration, controlled protein intake as appropriate, and reduced sodium consumption. May include referral to a renal dietitian for individualized meal planning.

dietary

Adequate hydration and fluid management

Maintaining optimal hydration status helps reduce the risk of cast nephropathy and supports overall renal function. Patients are encouraged to drink adequate fluids unless contraindicated by other conditions.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Bence Jones Proteinuria C0004968?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538-e548.

guideline2014
2

Hutchison CA, Batuman V, Behrens J, et al. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol. 2012;8(1):43-51.

review2012
3

Dispenzieri A, Zhang SK, Katzmann JA, et al. Monoclonal gammopathy of undetermined significance and survival in patients with renal dysfunction. J Clin Oncol. 2018;36(9):865-873.

clinical_trial2018
4

Leung N, Bridoux F, Batuman V, et al. The evaluation of monoclonal gammopathy of renal significance: consensus recommendations. Kidney Int. 2018;94(2):310-315.

review2018

Medication Comparisons

Compare medications used to treat Bence Jones Proteinuria C0004968. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy